Recent advances in optical mammography

Current Medical Imaging Reviews

Volumn 8, Issue 3, 2012, Pages 244-259

  Venugopal, Vivek ^a   Intes, Xavier ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Breast cancer; Diffuse optical tomography; Functional imaging; Optical imaging; Optical mammography

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; TAXANE DERIVATIVE;

BREAST CANCER; BREAST CARCINOMA; BREAST CYST; BREAST DISEASE; BREAST FIBROADENOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; DIAGNOSTIC IMAGING; FLUORESCENCE IMAGING; HUMAN; IMAGING SYSTEM; MAMMOGRAPHY; OPTICAL MAMMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

EID: 84869118828     PISSN: 15734056     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/157340512803759884     Document Type: Review

References (149)

1. Tromberg BJ, Pogue BW, Paulsen KD, Yodh AG, Boas DA, Cerussi AE. Assessing the future of diffuse optical imaging technologies for breast cancer management. Med Phys 2008; 35(6): 2443-51.
2. Intes X, Chance B. Non-PET functional imaging techniques: optical. Radiol. Clin North Am 2005; 43(1): 221-34, xii.
3. Thomsen S, Tatman D. Physiological and pathological factors of human breast disease that can influence optical diagnosis. Ann N Y Acad Sci 1998; 838: 171-93.
4. Woodard HQ, White DR. The composition of body tissues. Br J Radiol 1986; 59(708): 1209-18.
5. Vogel A, Venugopala n V. Mechanisms of Pulsed Laser Ablation of Biological Tissues. Chem Rev 2003; 103(2): 577-644.
6. Boulnois J-L. Photophysical processes in recent medical laser developments: A review. Lasers Med Sci 1986; 1(1): 47-66.
7. Taroni P, Comelli D, Pifferi A, Torricelli A, Cubeddu R. Absorption of collagen: effects on the estimate of breast composition and related diagnostic implications. J Biomed Opt 2007; 12: 014021.
8. Chung SH, Cerussi AE, Klifa C, et al. In vivo water state measurements in breast cancer using broadband diffuse optical spectroscopy. Phys Med Biol 2008; 53(23): 6713-27.
9. Welch AJ, Gemert MJC van. Opical-thermal response of laserirradiated tissue. Springer; 1995.
10. Cutler M. Transillumination of the breast. Ann Surg 1931; 93(1): 223-34.
11. Gros CM, Quenneville Y, Hummel Y. Diaphanologie mammaire. J Radiol Electrol Med Nucl 1972; 53: 297-306.
12. Profio AE, Navarro GA, Sartorius OW. Scientific basis of breast diaphanography. Med Phys 1989; 16(1): 60-5.
13. Ertefai S, Profio AE. Spectral transmittance and contrast in breast diaphanography. Med Phys 1985; 12(4): 393.
14. Carlson E. Diagnostic Imaging. S. Spectrascan and CT Windsor, eds; 1982.
15. Monsees B, Destouet JM, Totty WG. Light scanning versus mammography in breast cancer detection. Radiology 1987; 163(2): 463-5.
16. Monsees B, Destouet JM, Gersell D. Light scan evaluation of nonpalpable breast lesions. Radiology 1987; 163(2): 467-70.
17. Jobsis F. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977; 198(4323): 1264-7.
18. Yodh A, Chance B. Spectroscopy and imaging with diffusing light. Physics Today 1995; 48(3): 34-41.
19. Morse PM, Feshbach H. Methods of theoretical physics. McGraw-Hill; 1953.
20. Born M, Wolf E, Bhatia AB. Principles of Optics: Electromagnetic Theory of Propagation, Interference and Diffraction of Light. CUP Archive; 2000.
21. Chandrasekhar S. Radiative transfer. Courier Dover Publications; 1960.
22. Arridge SR. Optical tomography in medical imaging. Inverse problems 1999; 15: R41.
23. Arridge SR, Lionheart WRB. Nonuniqueness in diffusion-based optical tomography. Opt Lett 1998; 23(11): 882-4.
24. Gibson AP, Hebden JC, Arridge SR. Recent advances in diffuse optical imaging. Phys Med Biol 2005; 50(4): R1-R43.
25. Arridge SR, Hebden JC. Optical imaging in medicine: II. Modelling and reconstruction. Phys Med Biol 1997; 42: 841.
26. Lin Y, Lech G, Nioka S, Intes X, Chance B. Noninvasive, lownoise, fast imaging of blood volume and deoxygenation changes in muscles using light-emitting diode continuous-wave imager. Rev Sci Instrum 2002; 73(8): 3065.
27. Xu RX, Qiang B, Mao JJ, Povoski SP. Development of a handheld near-infrared imager for dynamic characterization of in vivo biological tissue systems. Appl Opt 2007; 46(30): 7442-51.
28. Colak SB, Van der Mark MB, Hooft GW, Hoogenraad JH, Van der Linden ES, Kuijpers FA. Clinical optical tomography and NIR spectroscopy for breast cancer detection. IEEE J Sel Top Quantum Electron 1999; 5(4): 1143-58.
29. Grable RJ, Ponder SL, Gkanatsios NA, Dieckmann W, Olivier P, FL IDSIP. Optical computed tomography for imaging the breast: First look 2000.
30. Culver JP, Choe R, Holboke MJ, et al. Three-dimensional diffuse optical tomography in the parallel plane transmission geometry: evaluation of a hybrid frequency domain/continuous wave clinical system for breast imaging. Med Phys 2003; 30(2): 235-47.
31. Siegel A, Marota JJ, Boas D. Design and evaluation of a continuous-wavediffuse optical tomography system. Opt Express 1999; 4(8): 287-98.
32. Lasker JM, Masciotti JM, Schoenecker M, Schmitz CH, Hielscher AH. Digital-signal-processor-based dynamic imaging system for optical tomography. Rev Sci Instrum 2007; 78(8): 083706.
33. Flexman ML, Khalil MA, Al Abdi R, et al. Digital optical tomography system for dynamic breast imaging. J Biomed Opt 2011; 16(7): 076014.
34. MB van der Mark, GW. 't Hooft, A.J.H. Wachters, U.H. de Vries, J. P. Janssen, M.N.J.M. Wasser. Clinical study of the female breast using spectroscopic diffuse optical tomography [Internet]. In: Li T, editor. Biomedical Optical Spectroscopy and Diagnostics. Optical Society of America; 2000 [cited 2010 Jul 29]. p. PD7. Available from: http://www.opticsinfobase.org.libproxy.rpi.edu/abstract. cfm?URI=BOSD-2000-PD7
35. van de Ven S, Elias S, Wiethoff A, et al. Diffuse optical tomography of the breast: initial validation in benign cysts. Mol Imaging Biol 2009; 11(2): 64-70.
36. Schmitz CH, Klemer DP, Hardin R, et al. Design and implementation of dynamic near-infrared optical tomographic imaging instrumentation for simultaneous dual-breast measurements. Appl Opt 2005; 44(11): 2140-53.
37. Yao Y, Wang Y, Pei Y, Zhu W, Barbour RL. Frequency-domain optical imaging of absorption and scattering distributions by a Born iterative method. J Opt Soc Am A 1997; 14(1): 325-42.
38. Intes X, Chance B. Multi-frequency diffuse optical tomography. J Mod Opt 2005; 52(15): 2139.
39. Nissilä I, Kotilahti K, Fallström K, Katila T. Instrumentation for the accurate measurement of phase and amplitude in optical tomography. Rev Sci Instrum 2002; 73: 3306.
40. Götz L, Heywang-Köbrunner SH, Schütz O, Siebold H. [Optical mammography in preoperative patients]. Aktuelle Radiol 1998; 8(1): 31-3.
41. MOESTAL K, Kaisers H, Fantini S, TONNIES M, Kaschke M, Schlag PM. Lasermammografie der brustdruse: Sensitivitatssteigrung durch hochfrequenzmodulation= Laser mammography of the breast: Sensitivity improvement by high frequency modulation. Langenbecks Archiv f\ür Chirurgie. Supplement 1996; (1): 543-548.
42. McBride TO, Pogue BW, Jiang S, Osterberg UL, Paulsen KD. A parallel-detection frequency-domain near-infrared tomography system for hemoglobin imaging of the breast in vivo. Rev Sci Instrum 2001; 72(3): 1817.
43. Corlu A, Durduran T, Choe R, et al. Uniqueness and wavelength optimization in continuous-wave multispectral diffuse optical tomography. Opt Lett 2003; 28(23): 2339-41.
44. Bevilacqua F, Berger AJ, Cerussi AE, Jakubowski D, Tromberg BJ. Broadband Absorption Spectroscopy in Turbid Media by Combined Frequency-Domain and Steady-State Methods. Appl Opt 2000; 39(34): 6498-507.
45. Wang J, Jiang S, Li Z, et al. In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography. Med Phys 2010; 37(7): 3715-24.
46. Ban HY, Lee K, Konecky SD, Choe R, Yodh AG. Next Generation Heterodyne Multi-Spectral Breast Imager. Biomedical Optics 2008.
47. Fang Q, Carp SA, Selb J, et al. Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression. IEEE Trans Med Imaging 2009; 28(1): 30-42.
48. No K-S, Kwong R, Chou PH, Cerussi A. Design and testing of a miniature broadband frequency domain photon migration instrument. J Biomed Opt 2008; 13(5): 050509.
49. Schweiger M, Arridge SR. Application of temporal filters to time resolved data in optical tomography. Phys Med Biol 1999; 44(7): 1699-1717.
50. Cubeddu R, Pifferi A, Taroni P, Torricelli A, Val entini G. Timeresolved imaging on a realistic tissue phantom: a images versus time-integrated images. Applied Optics 1996; 35(22): 4533-40.
51. Grosenick D, Wabnitz H, Rinneberg HH, Moesta KT, Schlag PM. Development of a time-domain optical mammograph and first in vivo applications. Appl Opt 1999; 38(13): 2927-43.
52. Pifferi A, Taroni P, Torricelli A, Messina F, Cubeddu R, Danesini G. Four-wavelength time-resolved optical mammography in the 680 980-nm range. Opt Lett 2003; 28(13): 1138-40.
53. Grosenick D, Hagen A, Steinkellner O, et al. A multichannel timedomain scanning fluorescence mammograph: performance assessment and first in vivo results. Rev Sci Instrum 2011; 82(2): 024302.
54. Intes X. Time-domain optical mammography SoftScan: initial results. Acad Radiol 2005; 12(8): 934-47.
55. Schmidt FEW, Fry ME, Hillman EMC, Hebden JC, Delpy DT. A 32-channel time-resolved instrument for medical optical tomography. Rev Sci Instrum 2000; 71(1): 256.
56. Intes X, Yu J, Yodh AG, Chance B. Development and evaluation of a multi-wavelength multi-channel timeresolved optical instrument for NIR/MRI mammography co-registration. In: Bioengineering Conference, 2002. Proceedings of the IEEE 28th Annual Northeast. 2002. p. 91-92.
57. Peters VG, Wyman DR, Patterson MS, Frank GL. Optical properties of normal and diseased human breast tissues in the visible and near infrared. Phys Med Biol 1990; 35(9): 1317-34.
58. Cheong WF, Prahl SA, Welch AJ. A review of the optical properties of biological tissues. IEEE journal of quantum electronics 1990; 26(12): 2166-85.
59. Intes X, Azar F. Advances in optical mammography. In: Advances in Optical Imaging for Clinical Medicine. John Wiley and Sons; 2011; 307-36.
60. Taroni P, Danesini G, Torricelli A, Pifferi A, Spinelli L, Cubeddu R. Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm. J Biomed Opt 2004; 9(3): 464-73.
61. Durduran T, Choe R, Culver JP, et al. Bulk optical properties of healthy female breast tissue. Phys Med Biol 2002; 47(16): 2847-61.
62. Spinelli L, Torricelli A, Pifferi A, Taroni P, Danesini GM, Cubeddu R. Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography. J Biomed Opt 2004; 9(6): 1137-42.
63. Shah N, Cerussi A, Eker C, et al. Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci USA 2001; 98(8): 4420-5.
64. Yates T, Hebden JC, Gibson A, Everdell N, Arridge SR, Douek M. Optical tomography of the breast using a multi-channel timeresolved imager. Phys Med Biol 2005; 50(11): 2503-17.
65. Suzuki K, Yamashita Y, Ohta K, Kaneko M, Yoshida M, Chance B. Quantitative measurement of optical parameters in normal breasts using time-resolved spectroscopy: in vivo results of 30 Japanese women. J Biomed Opt 1996; 1(3): 330-4.
66. Taroni P, Pifferi A, Spinelli L, et al. Optical Mammography at 635-1060 nm for Breast Density Assessment and Lesion Characterization. Biomedical Optics 2010
67. Taroni P, Pifferi A, Salvagnini E, Spinelli L, Torricelli A, Cubeddu R. Seven-wavelength time-resolved optical mammography extending beyond 1000 nm for breast collagen quantification. Opt Express 2009; 17(18): 15932-46.
68. Cerussi AE, Berger AJ, Bevilacqua F, et al. Sources of Absorption and Scattering Contrast for Near-Infrared Optical Mammography. Academic Radiology 2001; 8(3): 211-8.
69. Pifferi A, Swartling J, Chikoidze E, et al. Spectroscopic timeresolved diffuse reflectance and transmittance measurements of the female breast at different interfiber distances. J Biomed Opt 2004; 9(6): 1143-51.
70. Leff DR, Warren OJ, Enfield LC, et al. Diffuse optical imaging of the healthy and diseased breast: a systematic review. Breast Cancer Res Treat 2008; 108(1): 9-22.
71. Pogue BW, Poplack SP, McBride TO, et al. Quantitative Hemoglobin Tomography with Diffuse Near-Infrared Spectroscopy: Pilot Results in the Breast1. Radiology 2001; 218(1): 261-6.
72. Srinivasan S, Pogue BW, Brooksby B, et al. Near-infrared characterization of breast tumors in vivo using spectrally-constrained reconstruction. Technol. Cancer Res Treat 2005; 4(5): 513-26.
73. Grosenick D, Moesta KT, Wabnitz H, et al. Time-domain optical mammography: initial clinical results on detection and characterization of breast tumors. Appl Opt 2003; 42(16): 3170-86.
74. Spinelli L, Torricelli A, Pifferi A, Taroni P, Danesini G, Cubeddu R. Characterization of female breast lesions from multi-wavelength time-resolved optical mammography. Phys Med Biol 2005; 50(11): 2489-502.
75. Chance B, Nioka S, Zhang J, et al. Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol 2005; 12(8): 925-33.
76. Grosenick D, Moesta KT, Möller M, et al. Time-domain scanning optical mammography: I. Recording and assessment of mammograms of 154 patients. Phys Med Biol 2005; 50(11): 2429-49.
77. Pogue BW, Jiang S, Dehghani H, et al. Characterization of hemoglobin, water, and NIR scattering in breast tissue: analysis of intersubject variability and menstrual cycle changes. J Biomed Opt 2004; 9(3): 541-52.
78. Srinivasan S, Pogue BW, Jiang S, et al. Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography. Proceedings of the National Academy of Sciences of the United States of America 2003; 100(21): 12349-54.
79. Shah N, Cerussi AE, Jakubowski D, Hsiang D, Butler J, Tromberg BJ. Spatial variations in optical and physiological properties of healthy breast tissue. J Biomed Opt 2004; 9: 534.
80. Cerussi AE, Jakubowski D, Shah N, et al. Spectroscopy enhances the information content of optical mammography. J Biomed Opt 2002; 7(1): 60-71.
81. Poplack SP, Tosteson TD, Wells WA, et al. Electromagnetic Breast Imaging: Results of a Pilot Study in Women with Abnormal Mammograms1. Radiology 2007; 243(2): 350-9.
82. Fang Q, Moore RH, Kopans DB, Boas DA. Compositional-priorguided image reconstruction algorithm for multi-modality imaging. Biomed Opt Express 2010; 1(1): 223-35.
83. Soliman H, Gunasekara A, Rycroft M, et al. Functional Imaging Using Diffuse Optical Spectroscopy of Neoadjuvant Chemotherapy Response in Women with Locally Advanced Breast Cancer. Clin Cancer Res 2010; 16(9): 2605-14.
84. Fang Q, Selb J, Carp SA, et al. Combined Optical and X-ray Tomosynthesis Breast Imaging. Radiology 2011; 258(1): 89-97.
85. Knight JA, Blackmore KM, Wong J, Tharmalingam S, Lilge L. Optical spectroscopy of the breast in premenopausal women reveals tissue variation with changes in age and parity. Med Phys 2010; 37(2): 419-26.
86. Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL. Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ 2001; 154: 163-9.
87. Gram IT, Funkhouser E, Tabár L. The Tabár classification of mammographic parenchymal patterns. Eur J Radiol 1997; 24(2): 131-6.
88. Blackmore KM, Knight JA, Jong R, Lilge L. Assessing breast tissue density by transillumination breast spectroscopy (TIBS): an intermediate indicator of cancer risk. Br J Radiol 2007; 80(955): 545-56.
89. Taroni P, Pifferi A, Quarto G, Spinelli L, Torricelli A, Abbate F, et al. Noninvasive assessment of breast cancer risk using timeresolved diffuse optical spectroscopy. J Biomed Opt 2010; 15(6): 060501.
90. Tromberg BJ, Shah N, Lanning R, et al. Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2000; 2(1-2): 26-40.
91. Fantini S, Walker SA, Franceschini MA, Kaschke M, Schlag PM, Moesta KT. Assessment of the Size, Position, and Optical Properties of Breast Tumors in Vivo by Noninvasive Optical Methods. Appl Opt 1998; 37(10): 1982.
92. Teifke A, Behr O, Schmidt M, et al. Dynamic MR Imaging of Breast Lesions: Correlation with Microvessel Distribution Pattern and Histologic Characteristics of Prognosis1. Radiology 2006; 239(2): 351-60.
93. Hayat MA. Cancer imaging: Lung and breast carcinomas. Academic Press; 2008.
94. Grosenick D, Wabnitz H, Moesta KT, et al. Concentration and oxygen saturation of haemoglobin of 50 breast tumours determined by time-domain optical mammography. Phys Med Biol 2004; 49(7): 1165-81.
95. Grosenick D, Wabnitz H, Moesta KT, Mucke J, Schlag PM, Rinneberg H. Time-domain scanning optical mammography: II. Optical properties and tissue parameters of 87 carcinomas. Phys Med Biol 2005; 50(11): 2451-68.
96. Grosenick D, Moesta KT, Möller M, et al. Time-domain scanning optical mammography: I. Recording and assessment of mammograms of 154 patients. Phys Med Biol 2005; 50(11): 2429-49.
97. Rinneberg H, Grosenick D, Moesta K, et al. Detection and characterization of breast tumours by time-domain scanning optical mammography. Opto-Electronics Review 2008; 16(2): 147-62.
98. Choe R, Konecky SD, Corlu A, et al. Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography. J Biomed Opt 2009; 14(2): 024020.
99. Enfield LC, Gibson AP, Everdell NL, et al. Three-dimensional time-resolved optical mammography of the uncompressed breast. Applied optics 2007; 46(17): 3628-38.
100. Dehghani H, Pogue BW, Poplack SP, Paulsen KD. Multiwavelength Three-Dimensional Near-Infrared Tomography of the Breast: Initial Simulation, Phantom, and Clinical Results. Appl Opt 2003; 42(1): 135-45.
101. Zhu Q, Hegde PU, Ricci A Jr, et al. Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosis. Radiology 2010; 256(2): 367-78.
102. Kukreti S, Cerussi A, Tromberg B, Gratton E. Intrinsic tumor biomarkers revealed by novel double-differential spectroscopic analysis of near-infrared spectra. J Biomed Opt 2007; 12(2): 020509-3.
103. Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 2006; 11(4): 044005-16.
104. Busch DR, Guo W, Choe R, et al. Computer aided automatic detection of malignant lesions in diffuse optical mammography. Med Phys 2010; 37(4): 1840.
105. Kukreti S, Cerussi AE, Tanamai W, Hsiang D, Tromberg BJ, Gratton E. Characterization of Metabolic Differences between Benign and Malignant Tumors: High-Spectral-Resolution Diffuse Optical Spectroscopy1. Radiology 2010; 254(1): 277.
106. Tromberg BJ, Cerussi AE. Imaging Breast Cancer Chemotherapy Response with Light. Clinical Cancer Research 2010; 16(9): 2486-8.
107. Jakubowski DB, Cerussi AE, Bevilacqua F, et al. Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study. J Biomed Opt 2004; 9(1): 230-8.
108. Tromberg B, Cerussi A, Shah N, et al. Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Research 2005; 7(6): 279-285.
109. Cerussi AE, Tanamai VW, Mehta RS, Hsiang D, Butler J, Tromberg BJ. Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad Radiol 2010; 17(8): 1031-9.
110. Cerussi A, Hsiang D, Shah N, et al. Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci USA 2007; 104(10): 4014-9.
111. Pakalniskis MG, Wells WA, Schwab MC, et al. Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer? Radiology 2011; 259(2): 365-74.
112. Zhu Q, Tannenbaum S, Hegde P, Kane M, Xu C, Kurtzman SH. Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization. Neoplasia (New York, NY) 2008; 10(10): 1028.
113. Warner E. The role of magnetic resonance imaging in screening women at high risk of breast cancer. Top Magn Reson Imaging 2008; 19(3): 163-9.
114. Dromain C, Balleyguier C, Adler G, Garbay JR, Delaloge S. Contrast-enhanced digital mammography. European Journal of Radiology 2009; 69(1): 34-42.
115. van de Ven SMWY, Mincu N, Brunette J, et al. Molecular imaging using light-absorbing imaging agents and a clinical optical breast imaging system--a phantom study. Mol Imaging Biol 2011; 13(2): 232-238.
116. Knopp MV, Himmelhan N, Radeleff J, et al. Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography. Radiologe 2002; 42(4): 280-90.
117. Jackson A, Buckley DL, Parker GJM, editors. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology [Internet]. Berlin/Heidelberg: Springer-Verlag; 2005 [cited 2010 Jul 28]. Available from: http://ebooks.bibliothek.uni-regensburg.de/1323/
118. Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the Use of 18F-FDG PET in Oncology. J Nucl Med 2008; 49(3): 480-508.
119. Kuwana E, Sevick-Muraca EM. Fluorescence lifetime spectroscopy for pH sensing in scattering media. Anal Chem 2003; 75(16): 4325-9.
120. Bastiaens PI, Squire A. Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell. Trends Cell Biol 1999; 9(2): 48-52.
121. Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proceedings of the National Academy of Sciences 2000; 97(6): 2767.
122. Corlu A, Choe R, Durduran T, et al. Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt. Express 2007; 15(11): 6696-716.
123. Poellinger A, Burock S, Grosenick D, et al. Breast Cancer: Earlyand Late-Fluorescence Near-Infrared Imaging with Indocyanine Green-A Preliminary Study. Radiology 2011; 258(2): 409-16.
124. Feng D, Nagy JA, Dvorak HF, Dvorak AM. Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumorassociated microvessels in man and animals. Microsc. Res. Tech 2002; 57(5): 289-326.
125. Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156(4): 1363-80.
126. Hagen A, Grosenick D, Macdonald R, et al. Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions. Opt Express 2009; 17(19): 17016-33.
127. Intes X, Ripoll J, Chen Y, Nioka S, Yodh AG, Chance B. In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green Med Phys 2003; 30(6): 1039.
128. van de Ven S, Wiethoff A, Nielsen T, et al. A Novel Fluorescent Imaging Agent for Diffuse Optical Tomography of the Breast: First Clinical Experience in Patients. Molecular Imaging and Biology 2010; 12(3): 343-8.
129. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008; 452(7187): 580-9.
130. Leproux A, van der Voort M, van der Mark MB, Harbers R, van de Ven SMWY, van Leeuwen TG. Optical mammography combined with fluorescence imaging: lesion detection using scatterplots. Biomed Opt Express 2011; 2(4): 1007-20.
131. Jiang S, Pogue BW, Paulsen KD, Kogel C, Poplack SP. In vivo near-infrared spectral detection of pressure-induced changes in breast tissue. Optics letters 2003; 28(14): 1212-4.
132. Athanasiou A, Vanel D, Balleyguier C, et al. Dynamic optical breast imaging: a new technique to visualise breast vessels: comparison with breast MRI and preliminary results. Eur J Radiol 2005; 54(1): 72-9.
133. Fournier LS, Vanel D, Athanasiou A, et al. Dynamic optical breast imaging: A novel technique to detect and characterize tumor vessels. European Journal of Radiology 2009; 69(1): 43-9.
134. Jiang S, Pogue BW, Laughney AM, Kogel CA, Paulsen KD. Measurement of pressure-displacement kinetics of hemoglobin in normal breast tissue with near-infrared spectral imaging. Applied optics 2009; 48(10): 130-6.
135. Carp SA, Selb J, Fang Q, et al. Dynamic functional and mechanical response of breast tissue to compression. Opt. Express 2008; 16(20): 16064-78.
136. Carpenter CM, Rakow-Penner R, Jiang S, Pogue BW, Glover GH, Paulsen KD. Monitoring of hemodynamic changes induced in the healthy breast through inspired gas stimuli with MR-guided diffuse optical imaging. Med Phys 2010; 37(4): 1638-46.
137. Carpenter CM, Rakow-Penner R, Jiang S, et al. Inspired gasinduced vascular change in tumors with magnetic-resonanceguided near-infrared imaging: human breast pilot study. J. Biomed. Opt 2010; 15(3): 036026.
138. Dixit SS, Kim H, Comstock C, Faris GW. Near infrared transillumination imaging of breast cancer with vasoactive inhalation contrast. Biomed Opt Express 2010; 1(1): 295-309.
139. Li Z, Krishnaswamy V, Jiang S, Davis SC, Srinivasan S, Paulsen KD, et al. Rapid magnetic resonance-guided near-infrared mapping to image pulsatile hemoglobin in the breast. Opt Lett 2010; 35(23): 3964-6.
140. Huppert TJ, Hoge RD, Dale AM, Franceschini MA, Boas DA. Quantitative spatial comparison of diffuse optical imaging with blood oxygen level-dependent and arterial spin labeling-based functional magnetic resonance imaging. J Biomed Opt 2006; 11(6): 064018-16.
141. Carpenter CM, Pogue BW, Shudong Jiang, et al. MR Water Quantitative Priors Improves the Accuracy of Optical Breast Imaging. IEEE Transactions on Medical Imaging 2011; 30(1): 159-68.
142. Kuhl C. The Current Status of Breast MR Imaging Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice. Radiology 2007; 244(2): 356-78.
143. Carpenter CM, Pogue BW, Jiang S, et al. Image-guided optical spectroscopy provides molecular-specific information in vivo: MRI-guided spectroscopy of breast cancer hemoglobin, water, and scatterer size. Opt Lett 2007; 32(8): 933-5.
144. Zhang Q, Brukilacchio TJ, Li A, et al. Coregistered tomographic xray and optical breast imaging: initial results. Journal of biomedical optics 2005; 10: 024033.
145. Zhu Q, Tannenbaum S, Kurtzman SH. Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring. Surg Oncol Clin N Am 2007; 16(2): 307-21.
146. Zhu Q, Huang M, Chen N, et al. Ultrasound-Guided Optical Tomographic Imaging of Malignant and Benign Breast Lesions: Initial Clinical Results of 19 Cases. Neoplasia 2003; 5(5): 379-88.
147. Xu Y, Zhu Q. Imaging heterogeneous absorption distribution of advanced breast cancer by optical tomography. J Biomed Opt 2010; 15(6): 066007.
148. Freifelder R, Karp JS. Dedicated PET scanners for breast imaging. Physics in Medicine and Biology 1997; 42: 2463.
149. Konecky SD, Choe R, Corlu A, et al. Comparison of diffuse optical tomography of human breast with whole-body and breast-only positron emission tomography. Med Phys 2008; 35(2): 446-55.